1. Home
  2. Medical Research
  3. New York, NY
  4. Research to Prevent Blindness

Research to Prevent Blindness

Research to Prevent Blindness is ranked #22 of 39 medical research organizations in New York, NY, with an America's Best Score of 70 out of 100, based on its 2024 Form 990.

  • New York, NY
  • Tax-exempt since 1988
  • EIN: 13-1945117
rpbusa.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
70OF 100 #22 of 39 in New York ranked medical research organizations How this score is calculated

Organization summary

Research to Prevent Blindness is a 501(c)(3) organization, classified under Medical Research (NTEE H410). Contributions are tax-deductible.

360 Lexington Ave 22Nd Floor, New York, NY 10017-6528

Among the 61 scored medical research organizations in New York, Research to Prevent Blindness holds 28.6 months of operating reserves (peer median 13.5 months), runs a typical yearly surplus of 2.6% (peers: surplus of 3.4%), and has grown spending 7.1% a year (peers: grown spending 7.0% a year).

In fiscal year 2024 it reported $6,824,102 in revenue and $6,654,052 in expenses, with contributions making up 73.5% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2024 Form 990

To provide the organizational and financial resources necessary to support a comprehensive program of eye research.

Largest programs · fiscal year 2024

  • Research grants & research program development: During 2024, Research to Prevent Blindness, inc. (Rpb) made 20 grants to university medical schools to aid in the ophthalmological research of blinding eye disease. $4,505,370 spent · 77.4% of program spending
  • Public & professional information: Rpb disseminates the latest ophthalmological research findings to scientists, physicians & patients by publishing reports, brochures, and responses to inquiries. $939,607 spent · 16.1% of program spending
  • Scientific symposia, seminars & surveys: Rpb supports high-quality scientific meetings that are relevant to its scientific mission. Support of such meetings is contingent on the fiscal & programmatic interests & priorities of rpb. $374,857 spent · 6.4% of program spending

Where each dollar went · fiscal year 2024

Of every dollar it spent, 87¢ went to programs, 12¢ to management and 1¢ to fundraising.

  • Programs $5,819,834
  • Management $737,162
  • Fundraising $97,056

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score70 / 100
Rank in New York#22 of 39
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves28.6 mo; 8.9 mo in cash19.8 / 25
Financial balance (median margin)+2.6%5.6 / 20
Transparency3 full 990s, latest TY202420 / 20
Program growth+7.1% / yr11 / 15
Track record38 years10 / 10
Debt load42.1% of assets3.6 / 10
Total70 → 70
Spending on programs
Not scored; America's Best needs 65%+
87%Meets

Compared with New York peers

MeasureThis organizationPeer median
Operating reserves28.6 mo13.5 mo
Typical margin+2.6%+3.4%
Spending growth+7.1% / yr+7.0% / yr
Debt load42.1%13.5%

Peers: the 61 New York medical research organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$6,824,102Fiscal year 20242022: $16,445,23020222023: $4,863,01920232024: $6,824,1022024
Expenses$6,654,052Fiscal year 20242022: $5,804,45520222023: $6,651,55420232024: $6,654,0522024
Total assets$27,342,227Fiscal year 20242022: $25,282,96820222023: $26,306,97320232024: $27,342,2272024
Total liabilities$11,504,703Fiscal year 20242022: $9,347,26220222023: $10,979,63420232024: $11,504,7032024
Fiscal year ending December 2024
Revenue$6,824,102
Expenses$6,654,052
Net income$170,050
Net assets$15,837,524

Notable sources of revenue

Percent of total revenue
Contributions$5,016,630
Program services$0
Investment income$787,405
Other (net)$1,020,067

Assets / debt

Total assets$27,342,227
Total liabilities$11,504,703
Net assets$15,837,524

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$4,863,019
Expenses$6,651,554
Net income−$1,788,535
Net assets$15,327,339

Notable sources of revenue

Percent of total revenue
Contributions$3,107,826
Program services$0
Investment income$691,932
Other (net)$1,063,261

Assets / debt

Total assets$26,306,973
Total liabilities$10,979,634
Net assets$15,327,339

Compensation

Officers and key employees$544,313
Share of expenses8.2%
Fiscal year ending December 2022
Revenue$16,445,230
Expenses$5,804,455
Net income$10,640,775
Net assets$15,935,706

Notable sources of revenue

Percent of total revenue
Contributions$15,001,025
Program services$0
Investment income$512,234
Other (net)$931,971

Assets / debt

Total assets$25,282,968
Total liabilities$9,347,262
Net assets$15,935,706

Compensation

Officers and key employees$513,382
Share of expenses8.8%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?